N-(4-Methylcinnamoyl)anthranilic acid

ID: ALA4557362

PubChem CID: 11666329

Max Phase: Preclinical

Molecular Formula: C17H15NO3

Molecular Weight: 281.31

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1

Standard InChI:  InChI=1S/C17H15NO3/c1-12-6-8-13(9-7-12)10-11-16(19)18-15-5-3-2-4-14(15)17(20)21/h2-11H,1H3,(H,18,19)(H,20,21)/b11-10+

Standard InChI Key:  RYGGYSHFHOMWTD-ZHACJKMWSA-N

Molfile:  

 
     RDKit          2D

 21 22  0  0  0  0  0  0  0  0999 V2000
   36.0417  -10.0993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0405  -10.9188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7486  -11.3278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4582  -10.9184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4554  -10.0957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7468   -9.6904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1616   -9.6844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8708  -10.0904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5770   -9.6791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2862  -10.0850    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.5739   -8.8619    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.9924   -9.6738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6976  -10.0814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4033   -9.6709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4007   -8.8528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6865   -8.4471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9837   -8.8600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6988  -10.8986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4071  -11.3062    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.9917  -11.3082    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.3325  -11.3269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 13 18  1  0
 18 19  1  0
 18 20  2  0
  2 21  1  0
M  END

Associated Targets(Human)

TRPA1 Tclin Transient receptor potential cation channel subfamily A member 1 (1847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TRPM8 Tclin Transient receptor potential cation channel subfamily M member 8 (1168 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TRPM2 Tchem Transient receptor potential cation channel subfamily M member 2 (348 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 281.31Molecular Weight (Monoisotopic): 281.1052AlogP: 3.35#Rotatable Bonds: 4
Polar Surface Area: 66.40Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.55CX Basic pKa: CX LogP: 4.39CX LogD: 1.03
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.84Np Likeness Score: -0.65

References

1. Chandrabalan A, McPhillie MJ, Morice AH, Boa AN, Sadofsky LR..  (2019)  N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites.,  170  [PMID:30878828] [10.1016/j.ejmech.2019.02.074]
2. Zhang H, Yu P, Lin H, Jin Z, Zhao S, Zhang Y, Xu Q, Jin H, Liu Z, Yang W, Zhang L..  (2021)  The Discovery of Novel ACA Derivatives as Specific TRPM2 Inhibitors that Reduce Ischemic Injury Both In Vitro and In Vivo.,  64  (7.0): [PMID:33784097] [10.1021/acs.jmedchem.0c02129]

Source